Acquisition of CorHepta - Schedule of fair value of consideration transferred (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Feb. 21, 2025 |
Dec. 31, 2025 |
|
| Fair Value, Recurring | ||
| Business Combination [Line Items] | ||
| Fair value of consideration | $ 7,338,719 | |
| Fair Value, Recurring | Series of Individually Immaterial Asset Acquisitions | ||
| Business Combination [Line Items] | ||
| Contingent consideration | $ 4,435,443 | |
| CorHepta Pharmaceuticals [Member] | ||
| Business Combination [Line Items] | ||
| Fair value of consideration | $ 7,400,000 | |
| CorHepta Pharmaceuticals [Member] | Common Stock | ||
| Business Combination [Line Items] | ||
| Shares vested | 829,849 | 829,849 |
| Shares representing contingent consideration | 2,489,030 | 1,493,415 |
| Share Price at Closing | $ 2.97 | |
| CorHepta Pharmaceuticals [Member] | Fair Value, Recurring | ||
| Business Combination [Line Items] | ||
| Fair Value of Fully Vested Shares | $ 2,464,652 | |
| Transaction costs incurred by the Company | 438,624 | |
| Fair value of consideration | $ 7,338,719 |
| X | ||||||||||
- Definition Fair Value of Fully Vested Shares No definition available.
|
| X | ||||||||||
- Definition Shares Representing Contingent Consideration No definition available.
|
| X | ||||||||||
- Definition Shares Vested on Acquisition No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|